OSI PHARMACEUTICALS, INC. CONSULTING AND CONFIDENTIAL DISCLOSURE AGREEMENTConsulting and Confidential Disclosure Agreement • May 8th, 2009 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This Consulting and Confidential Disclosure Agreement (“Agreement”) is effective as of the date of the last party to sign below (“Effective Date”) by and between OSI Pharmaceuticals, Inc., a Delaware corporation (together with its affiliates and subsidiaries, “OSI”), having executive offices at 41 Pinelawn Road, Melville, New York 11747, and H.M. (Bob) Pinedo, M.D., Ph.D., an individual (“Consultant”), having an address at Gladiolenweg 6, Willemstad, Curacao, Netherlands Antilles.
